United States

Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

8 Dec 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for HOFBC.OL


Hofseth BioCare ASA (HBC) is a Norway-based company, engaged in providing biomarine ingredients for human and animal applications, such as dietary supplements, sport nutrition, functional food and natural health products, animal feed additives and pet food. The Company’s product portfolio comprises Soluble Protein (SPH), which... (more)
No analyst recommendations are available for HOFBC.OL.


Beta: 0.13
Market Cap(Mil.): kr326.90
Shares Outstanding(Mil.): 233.50
Dividend: --
Yield (%): --


  HOFBC.OL Industry Sector
P/E (TTM): -- 26.80 40.35
EPS (TTM): -1.23 -- --
ROI: -123.03 12.67 59.37
ROE: -410.00 16.59 67.09

BRIEF-Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln

* Reported on Thursday Q3 operating revenues of 3.6 million Norwegian crowns ($420,000) versus 16.6 million crowns year ago

Nov 18 2016

BRIEF-Hofseth Biocare reports final results of Subsequent Offering

* Said on Monday the subscription period for the Subsequent Offering had ended

Oct 18 2016

BRIEF-Hofseth Biocare receives patent in the European Union

* Announces grant of its European patent application no. 08861633.9 for compositions and methods for increasing iron absorption Source text for Eikon:

Oct 05 2016

BRIEF-Hofseth Biocare Q2 operating loss widens to NOK 47.5 million

* Q2 operating revenue 8.2 million Norwegian crowns ($989,848) versus 6.4 million crowns year ago

Aug 29 2016

BRIEF-Hofseth biocare announces equity issue of minimum NOK 165 mln

* Announces an equity issue of minimum 165 million Norwegian crowns ($20 million) at a subscription price of 1.50 per share crown

Aug 29 2016

BRIEF-Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo

* US patent office has issued a Notice of Allowance on one of HBC's key licensed-in salmon oil patent applications

Aug 02 2016

Earnings vs. Estimates